DD

Dhanjit Deka

Active Director Director DIN 08292190
DIN 08292190 First appointment Nov 2018 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2018
Shareholding value •••• Premium profile

About Dhanjit Deka

Data last updated:

Dhanjit Deka is a Director at Lumos Drugs & Surgical Private Limited (since 2018). The company operates in Healthcare. Lumos Drugs & Surgical Private Limited reported revenue of ₹36.6 Lakh (FY 2025).

DIN 08292190
Primary Designation Director
Industry Healthcare
First Appointment 30 Nov 2018
Oldest Company Age 7 yrs
Largest company Lumos Drugs & Surgical Private Limited · ₹36.6 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 Nov 20182018₹36.6 Lakh (FY 2025)Active

Board colleagues of Dhanjit Deka

NameDINCompanyDesignation
Tejash Kamal Phukan08292191Lumos Drugs & Surgical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Lumos Drugs & Surgical Private Limited
Premium access

Shareholding and investment profile for Dhanjit Deka

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dhanjit Deka

Dhanjit Deka currently holds 1 directorship: Lumos Drugs & Surgical Private Limited (Director, since 30 Nov 2018, revenue ₹36.6 Lakh (FY 2025)).

Dhanjit Deka was first appointed on 30 Nov 2018 as Director at Lumos Drugs & Surgical Private Limited.

The current boards of Dhanjit Deka's companies include Tejash Kamal Phukan (Lumos Drugs & Surgical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available